Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Receivables: 2009-2024

Historic Receivables for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $288.5 million.

  • Pediatrix Medical's Receivables fell 8427.39% to $231.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.1 million, marking a year-over-year decrease of 8427.39%. This contributed to the annual value of $288.5 million for FY2024, which is 7957.47% down from last year.
  • Latest data reveals that Pediatrix Medical reported Receivables of $288.5 million as of FY2024, which was down 7957.47% from $1.4 billion recorded in FY2023.
  • Pediatrix Medical's Receivables' 5-year high stood at $1.6 billion during FY2022, with a 5-year trough of $288.5 million in FY2024.
  • Its 5-year average for Receivables is $1.2 billion, with a median of $1.4 billion in 2023.
  • In the last 5 years, Pediatrix Medical's Receivables soared by 2430.99% in 2021 and then tumbled by 7957.47% in 2024.
  • Pediatrix Medical's Receivables (Annual) stood at $1.2 billion in 2020, then grew by 24.31% to $1.5 billion in 2021, then increased by 10.44% to $1.6 billion in 2022, then decreased by 11.9% to $1.4 billion in 2023, then crashed by 79.57% to $288.5 million in 2024.
  • Its last three reported values are $288.5 million in FY2024, $1.4 billion for FY2023, and $1.6 billion during FY2022.